Keywords: gsk, 1st-qtr, profit, falls, generic, competition, uk
GSK's 1st-qtr profit falls 13.5% on US generic competition
Article | 22 April 2009
UK drug major GlaxoSmithKline's first-quarter 2009 profit fell 13.5% year-on-year to GBP1.13 billion ($1.64 billion), due to one-off R&D writedowns and generic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
